Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

428.26 0.17 −0.04%
Market cap
$92.9B
P/E
19.0×
Fwd P/E
20.3×
Dividend yield
1.60%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100

Elevance Health, Inc. (ELV) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Elevance Health, Inc. (ELV) trades at a EV/Sales of 0.4×. Over the past ten years it has ranged from 0.3× (November 2016) to 0.8× (February 2019); the current reading is higher than 29% of that period. That is above the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.4× (19.10%)
FY2024 0.5× (22.12%)
FY2023 0.6× (15.75%)
FY2022 0.7× (5.14%)
FY2021 0.7× 29.34%
FY2020 0.6× (15.81%)
FY2019 0.7× (0.67%)
FY2018 0.7× 17.07%
FY2017 0.6× 70.44%
FY2016 0.3× (11.81%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.4× 32.16%
Mar 2026 0.3× (21.92%)
Dec 2025 0.4× 7.15%
Sep 2025 0.3× (20.24%)
42 more quarters

Against its own ten years

Low 0.3× High 0.8×
Ten-year median 0.6×
Current reading's percentile 26

EV/Sales against peers

Company EV/Sales
CNC Centene Corporation compare 0.1×
MOH Molina Healthcare, Inc compare 0.1×
HUM Humana Inc. compare 0.3×
CI Cigna Group compare 0.4×
OSCR Oscar Health, Inc. compare 0.4×
CVS CVS Health Corporation compare 0.4×
ELV Elevance Health, Inc. 0.4×
CLOV Clover Health Investments, Corp. compare 0.9×
UNH UnitedHealth Group Incorporated compare 0.9×
Healthcare Plans industry median 0.4×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ELV